Findings

What do systematic reviews say?

7 questions · 7 findings · 3 reviews

No studies found 2 · 28.6%GRADE not reported 0 · 0%Very low 2 · 28.6%Low 2 · 28.6%Moderate 1 · 14.3%High 0 · 0%

Mortality (up to 90 days) · orthopaedic (hip)

1 finding from 1 review

Mortality (up to 90 days) · orthopaedic (mixed)

It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).

1 finding from 1 review

Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery

1 finding from 1 review

The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
0.99 [0.61, 1.6]
3 studies · 4758 participants
Moderate

Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery

1 finding from 1 review

The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
0.83 [0.54, 1.29]
6 studies · 4525 participants
Low

All‐cause mortality (up to 30 days) · adults undergoing non‐cardiac surgery

Continuation showed no clear difference in all‐cause mortality (up to 30 days) compared with discontinuation of antiplatelet therapy (low certainty).

1 finding from 1 review

Mortality (up to 90 days) ‐ not reported · orthopaedic (knee)

The review found no eligible studies for this question.

1 finding from 1 review

Mortality (up to 90 days) ‐ not reported · orthopaedic (spinal)

The review found no eligible studies for this question.

1 finding from 1 review